Upgrade to SI Premium - Free Trial

Wolfe Research Upgrades Madrigal Pharmaceuticals (MDGL) to Outperform

August 4, 2026 5:07 AM
(Updated - August 4, 2026 5:08 AM EDT)

Wolfe Research analyst Andy Chen upgraded Madrigal Pharmaceuticals (NASDAQ: MDGL) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Hot Comments Hot Upgrades Upgrades